News Network

OncLive News Network: On Location at ASCO 2021

May 25th 2021

Join us LIVE at this year's virtual 2021 ASCO Annual Meeting! OncLive® will broadcast a series of interviews with top thought leaders in breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic malignancies, and hematologic malignancies. The experts will share their insights and reactions to the pivotal data presented during the conference.


Post-Conference Perspectives: RxPONDER, SABCS 2020

May 7th 2021

Priyanka Sharma, MD, and Lajos Pusztai, MD, PhD, discuss the practice-changing results and real-world implications of the RxPONDER trial for patients with HR+ HER2- breast cancer.

Post Conference Perspectives: Trilaciclib, a New Option for Chemotherapy-Induced Myelosuppression

May 6th 2021

Ralph Boccia, MD and Jim Schwartz, RPh provide key insights into the recent FDA approval of trilaciclib and discuss its impact on the treatment landscape for extensive-stage small cell lung cancer.

The Next Steps for CAR T-Cell Therapy in DLBCL

April 27th 2021

Amit Patel, BSc, MBBS, PhD, reviews key takeaways from the 2021 European Society for Blood and Marrow Transplantation symposium regarding the use of CAR T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma.

Exciting Approval in Europe for HER2-Positive Breast Cancer

April 7th 2021

Post-Conference Perspectives: ASCO GU 2021

March 8th 2021

The Role of Circulating Tumor (ct)DNA Testing/Monitoring in Stage II-III Colorectal Cancer

February 15th 2021

ASCO GU 2021 News

February 12th 2021

Chemotherapy-Free Intervals in Management of Metastatic Colorectal Cancer

January 22nd 2021

The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer

January 19th 2021